These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 25385756)

  • 21. Viral Envelope Evolution in Simian-HIV-Infected Neonate and Adult-Dam Pairs of Rhesus Macaques.
    Giorgi EE; Li H; Hora B; Shaw GM; Wagh K; Williams WB
    Viruses; 2024 Jun; 16(7):. PubMed ID: 39066177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia.
    Nishimura Y; Donau OK; Dias J; Ferrando-Martinez S; Jesteadt E; Sadjadpour R; Gautam R; Buckler-White A; Geleziunas R; Koup RA; Nussenzweig MC; Martin MA
    J Exp Med; 2021 Jan; 218(1):. PubMed ID: 32966579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
    Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
    AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys.
    Borducchi EN; Liu J; Nkolola JP; Cadena AM; Yu WH; Fischinger S; Broge T; Abbink P; Mercado NB; Chandrashekar A; Jetton D; Peter L; McMahan K; Moseley ET; Bekerman E; Hesselgesser J; Li W; Lewis MG; Alter G; Geleziunas R; Barouch DH
    Nature; 2018 Nov; 563(7731):360-364. PubMed ID: 30283138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunity.
    Shapiro MB; Cheever T; Malherbe DC; Pandey S; Reed J; Yang ES; Wang K; Pegu A; Chen X; Siess D; Burke D; Henderson H; Lewinsohn R; Fischer M; Stanton JJ; Axthelm MK; Kahl C; Park B; Lewis AD; Sacha JB; Mascola JR; Hessell AJ; Haigwood NL
    Nat Commun; 2020 Jan; 11(1):70. PubMed ID: 31911610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
    Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
    J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection.
    Parsons MS; Lloyd SB; Lee WS; Kristensen AB; Amarasena T; Center RJ; Keele BF; Lifson JD; LaBranche CC; Montefiori D; Wines BD; Hogarth PM; Swiderek KM; Venturi V; Davenport MP; Kent SJ
    Sci Transl Med; 2017 Aug; 9(402):. PubMed ID: 28794282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-infection immunodeficiency virus control by neutralizing antibodies.
    Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T
    PLoS One; 2007 Jun; 2(6):e540. PubMed ID: 17579714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutralizing antibodies administered before, but not after, virulent SHIV prevent infection in macaques.
    Foresman L; Jia F; Li Z; Wang C; Stephens EB; Sahni M; Narayan O; Joag SV
    AIDS Res Hum Retroviruses; 1998 Aug; 14(12):1035-43. PubMed ID: 9718118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1.
    Dunn CS; Hurtrel B; Beyer C; Gloeckler L; Ledger TN; Moog C; Kieny MP; Mehtali M; Schmitt D; Gut JP; Kirn A; Aubertin AM
    AIDS Res Hum Retroviruses; 1997 Jul; 13(11):913-22. PubMed ID: 9223407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV escape: there and back again.
    Altman JD; Feinberg MB
    Nat Med; 2004 Mar; 10(3):229-30. PubMed ID: 14991039
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection.
    Derby NR; Kraft Z; Kan E; Crooks ET; Barnett SW; Srivastava IK; Binley JM; Stamatatos L
    J Virol; 2006 Sep; 80(17):8745-62. PubMed ID: 16912322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tandem bispecific antibody prevents pathogenic SHIV
    Niu M; Wong YC; Wang H; Li X; Chan CY; Zhang Q; Ling L; Cheng L; Wang R; Du Y; Yim LY; Jin X; Zhang H; Zhang L; Chen Z
    Cell Rep; 2021 Aug; 36(8):109611. PubMed ID: 34433029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.
    Veazey RS; Shattock RJ; Pope M; Kirijan JC; Jones J; Hu Q; Ketas T; Marx PA; Klasse PJ; Burton DR; Moore JP
    Nat Med; 2003 Mar; 9(3):343-6. PubMed ID: 12579198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies.
    Mascola JR; Stiegler G; VanCott TC; Katinger H; Carpenter CB; Hanson CE; Beary H; Hayes D; Frankel SS; Birx DL; Lewis MG
    Nat Med; 2000 Feb; 6(2):207-10. PubMed ID: 10655111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection.
    Shytaj IL; Nickel G; Arts E; Farrell N; Biffoni M; Pal R; Chung HK; LaBranche C; Montefiori D; Vargas-Inchaustegui D; Robert-Guroff M; Lewis MG; Sacha JB; Palamara AT; Savarino A
    J Virol; 2015 Aug; 89(15):7521-35. PubMed ID: 25972547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis.
    Spencer DA; Goldberg BS; Pandey S; Ordonez T; Dufloo J; Barnette P; Sutton WF; Henderson H; Agnor R; Gao L; Bruel T; Schwartz O; Haigwood NL; Ackerman ME; Hessell AJ
    Nat Commun; 2022 Feb; 13(1):662. PubMed ID: 35115533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
    Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
    J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole body positron emission tomography imaging of activated lymphoid tissues during acute simian-human immunodeficiency virus 89.6PD infection in rhesus macaques.
    Wallace M; Pyzalski R; Horejsh D; Brown C; Djavani M; Lu Y; Hanson JM; Mitchen JL; Perlman SB; Pauza CD
    Virology; 2000 Sep; 274(2):255-61. PubMed ID: 10964769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonpathogenic simian immunodeficiency virus infection of sooty mangabeys is not associated with high levels of autologous neutralizing antibodies.
    Li B; Stefano-Cole K; Kuhrt DM; Gordon SN; Else JG; Mulenga J; Allen S; Sodora DL; Silvestri G; Derdeyn CA
    J Virol; 2010 Jun; 84(12):6248-53. PubMed ID: 20375163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.